Higher Exchanges cover art

All Episodes

Higher Exchanges — 101 episodes

#
Title
1

Can Cannabis Grow Again? | Episode 100 with Nick Gastevich

2

DEA, Virginia & the Future of Cannabis

3

Cannabis Rescheduling Is Here. What Happens Next? | Hirsh Jain

4

Cannabis Lending After Schedule III with Steven Ernest of Chicago Atlantic

5

Is Cannabis Finally Investable Again? Rescheduling, GTI, Vireo & C21 Deep Dive

6

Finding Alpha in Cannabis: Allocation, Debt, and What Actually Works w/ Jerry Derevyanny

7

LEEF Q4 2025 Earnings Review: Inside the Transformation with CEO Micah Anderson

8

Inside the World’s Leading Cannabis Company | Curaleaf CEO Boris Jordan on Rescheduling, Capital Markets, and Consolidation

9

Is CBD Back? A Conversation with Bill Morachnick, CEO of Charlotte’s Web

10

Five Hard Questions Facing Cannabis Investors

11

TerrAscend at a Turning Point: Federal Reform, Capital Strategy, and the Path Forward

12

Cannabis Rescheduling: A Tailwind for the Cannabis 2.0 M&A Cycle

13

Cannabis Schedule III Breakdown: What It Means for Policy, Capital Markets, and Investors

14

2025 Cannabis Investing Review & 2026 Preview

15

What the Hemp Is Going On? — with Whitt Steineker

16

Q3 Earnings Review with LEEF Brands CEO Micah Anderson

17

Cannabis Done Right with Jetty CEO Ron Gershoni

18

Minnesota's New Era with Aaron Edelheit

19

The Future of Intoxicating Hemp with Tucker Johnson

20

Building Momentum with Aaron Miles, CIO of Verano

21

Elevating the Game with Jamie Medola

22

Tier One MSO Earnings – Q2 2025 Highlights

23

Know What You Own Starring Scott Grossman

24

New York is Rising Starring Jeff Schultz

25

Conquering the Universe with Ted Lidie, Founder of Alien Labs

26

The Path Forward Starring Sammy J

27

Conferences, Courts, and Cannabis Updates

28

The Unfiltered Truth with Seth Yakatan

29

The Global Playbook with Zachary George, CEO of SNDL

30

Where’s the Growth? Starring Hirsh Jain

31

How to Win in Cannabis with Mitchell Osak

32

Grow Smarter: Learning from Cannabis Failures

33

Deep Dive with Colin Ferrian: Credit Markets, Pricing Trends, and the Hemp Industry

34

Navigating the New Cannabis Landscape with Ascend’s Sam Brill

35

The Future of the Cannabis Industry with FiSai's Erich Mauf

36

Jason Wild & Ziad Ghanem Break Down TerrAscend’s 2024 Growth & Future Plans

37

Breaking Down Cannabis Earnings with CannaVestments

38

The Road Ahead: Sammy J’s Take on Cannabis Industry Recovery

39

Can Cannabis Stocks Recover? Insights from Turning Point Brands' Scott Grossman

40

How to Play the Cannabis Beverage Boom With Craig Lewis, Founder & CEO of Flyers Cocktail Co.

41

Four Fundamental Catalysts with LEEF Brands CEO, Micah Anderson

42

Signs of Recovery With Kyle Sherman, Founder and CEO of Flowhub

43

Is the MSO Model Broken Starring Jerry Derevyanny

44

2025 Cannabis Investing Predictions

45

Hemp is Living the Cannabis Dream

46

Boise Schiller Flexner Case Next Steps With Jason Wild, Emily Paxhia, Erik Luna, and Weldon Angelos

47

Adapting to Change With AYR Interim CEO Steven M. Cohen

48

Unlocking Potential With Ascend CEO Sam Brill

49

Revisiting the Thesis With Dai Truong and Doug Kass

50

2024 Election Preview Starring Hirsh Jain

51

The Sunshine State Starring Dan Neville and Brady Cobb

52

Three Benzinga Takeaways

53

Who’s Better for Cannabis: Harris or Trump?

54

Efficient Craft Cannabis With Grown Rogue CEO Obie Strickler

55

Finding Florida Opportunities With Emily Paxhia

56

Farm Bill Flower Opportunities With Kyle Kazan and Graham Farrar

57

Unpacking Political Catalysts With Jeff Schultz

58

Harvesting Adult-Use Opportunities With AYR Wellness With CEO David Goubert

59

Catching Up With CannaVestments

60

Operator Spotlight: TerrAscend With Jason Wild and Ziad Ghanem

61

Trump Tips His Hand On Cannabis Policy

62

S3 Comments Review and 2Q Earnings Preview

63

Mid-2024 State Catalyst Review With Hirsh Jain

64

Mid-2024 Federal Catalyst Review

65

Curaleaf’s Hemp-Derived THC Launch With CEO Matt Darin

66

Optimizing Assets With The Cannabist Company CEO David Hart

67

The Blame Game

68

Merger Mania

69

Reality Doesn't Bite

70

Rescheduling Reaction and Earnings Review With CannaVestments

71

Political and Earnings Updates With Cresco CEO Charlie Bachtell

72

Cash Flow Is King With Verano’s George Archos

73

The DEA Agrees With Schedule III Starring Boris Jordan and Hirsh Jain

74

Waiting on the World to Change

75

The Waiting Is the Hardest Part

76

The Catalyst Table Starring Hirsh Jain

77

Florida Update With AYR Wellness CEO David Goubert

78

Cannabis Catalyst Update With Sammy J

79

TerrAscend Q4 2023 Earnings Review with Jason Wild and Ziad Ghanem

80

Ascend Q4 2023 Earnings Review with CEO John Hartmann

81

Curaleaf Earnings Review with Boris Jordan and CannaVestments

82

GTI, Trulieve, and Verano Q4 Earnings Reviews

83

Earnings Preview and Germany Review With Boris Jordan

84

The Thesis Is in Tact Starring Sammy J

85

Do Valuations Matter?

86

The Improving Risk-Reward Equation for US Cannabis

87

Appreciating the Good Times With Verano’s Darren Weiss and Aaron Miles

88

Reviewing the HHS Recommendation With Brady Cobb and Boris Jordan

89

Returning to Growth

90

2024 Cannabis Investing Preview

91

Recapping 2023's Top Cannabis Investing Stories

92

Curaleaf Uplisting With Boris Jordan

93

Ascend Review With John Hartmann

94

What’s the Bear Case?

95

AYR Earnings Review With David Goubert

96

Verano Earnings Review With Darren Weiss and Aaron Miles

97

Analyzing the Drawdown

98

Potential New States and a Groundbreaking Lawsuit

99

TerrAscend Review With Jason Wild, Ziad Ghanem, and Keith Stauffer

100

TSX and DC Updates With Boris Jordan

101

The Origin Story